Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-06

FDA Approved: ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Ingenus Pharmaceuticals' original application (ANDA 215586) for Isosorbide Dinitrate and Hydralazine Hydrochloride. The product is a fixed-dose com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Dinitrate and Hydralazine Hydrochloride (Isosorbide Dinitrate and Hydralazine Hydrochloride)

Snippet

ORIG AP for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE (ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE)